This week's funding spotlights a featured speaker at next week's Civic Health Forum: Ilant Health. The New York, NY-based provider of an AI-supported precision obesity and cardiometabolic care platform raised $15M led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX, and AlphaLab. <source> 

Other reported global health innovation funding this week includes: 

NewLimit, a South San Francisco, CA-based longevity biotechnology company, raised $435M led by Founders Fund, with participation from Thrive Capital, Lilly Ventures, Nat Friedman, and Daniel Gross. <source>

Lila Sciences, a Cambridge, MA-based developer of a scientific superintelligence platform and automated laboratory systems, raised $350M co-led by Braidwell and Collective Global, with participation from NVentures, Analog Devices, IQT, Dauntless Ventures, Catalio Capital Management, Pennant Investors, Flagship Pioneering, Altitude Life Science Ventures, General Catalyst, and the Abu Dhabi Investment Authority. <source>

CeQur, a Horw, Switzerland-based company focused on improving mealtime insulin delivery for people living with diabetes, raised $100M from undisclosed investors. <source>

Collate, a San Francisco, CA-based developer of AI-powered document automation software for the life sciences sector, raised $95M led by Redpoint Ventures, with participation from First Round Capital and Conviction Partners. <source>

CereVasc, a Boston, MA-based clinical-stage medical device company developing minimally invasive treatments for neurological diseases, raised $85M led by Piper Sandler Merchant Banking, with participation from Johnson & Johnson Innovation – JJDC, Medtronic, Bain Capital Life Sciences, and Perceptive Xontogeny Venture Funds. <source>

Stepful, a New York, NY-based AI-powered healthcare workforce training platform, raised $55M led by Oak HC/FT, with participation from Foresite Capital, Hearst Ventures, Citi Impact Fund, Y Combinator, and Intermountain Health. <source>

Adaptive Innovations, a New York, NY- and Dallas, TX-based developer of an AI-native home healthcare operating system and clinical services platform, raised $50M co-led by Felicis and Bain Capital Ventures, with participation from Optum Ventures, Sunflower Capital, Conviction, BoxGroup, SV Angels, Dorm Room Fund, and Constellation. <source>

Semble, a London, UK-based practice management and care coordination platform for outpatient healthcare providers, raised £30M (~$40.2M) led by Revaia, with participation from Partech, Mercia Ventures, and Octopus Ventures. <source>

Apoha, a London, UK-based developer of a molecular behavior data layer for drug discovery and physical-world AI, raised $36M led by Singular, with participation from Draper Associates, Seedcamp, Redalpine, Wilbe, and Nucleus. <source>

Lassie, a San Francisco, CA-based developer of autonomous AI systems for healthcare practice administration, raised $35M led by Andreessen Horowitz, with participation from Night Capital and angel investors including Rahul Vohra, Zach Perret, Taavet Hinrikus, Gokul Rajaram, and Brian Balfour. <source>

Subtle Medical, a Menlo Park, CA-based developer of AI-powered medical imaging software, raised $33M led by Morgan Stanley Expansion Capital, with participation from Shinhan Venture Investment, Fusion Fund, EnvisionX, BRV, and Samsung Ventures. <source>

Oak Hill Bio, a Cambridge, MA-based clinical-stage rare disease therapeutics company, raised $32.5M co-led by Balyasny Asset Management, venBio, and Janus Henderson Investors, with participation from KCap Biotechnology Fund. <source>

Klinic, a Frisco, TX-based startup that offers a digital enablement platform for specialty healthcare providers, raised $24M from undisclosed investors. <source>

Novellia, a New York, NY-based startup providing a patient-powered real-world data and personal health records platform, raised $18M led by Spark Capital, with participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV. <source>

Join StartUp Health

A global community for the bold decision makers, thought leaders, funders, and innovators transforming the future of health – this is where the global health ecosystem comes together to learn from experts, share insights, build relationships, explore partnerships, and shape what’s next in health.

👉 Join today, no application necessary

Tavo Biotherapeutics, a Laguna Beach, CA-based developer of novel therapeutics for glaucoma and retinal disease, raised $17M led by Pureos Bioventures, with participation from Polaris Partners and Tau Capital. <source>

Flok Health, a Cambridge, UK-based developer of an AI-operated physiotherapy clinic platform for NHS and outpatient providers, raised $12.5M led by Albion VC, with participation from Eka Ventures, Form Ventures, and Mercia Ventures. <source>

Scispot, a Kitchener, ON, Canada-based developer of an AI-native operating layer for modern labs, raised $8M led by Avenue Growth Partners. <source>

Thea, a New Castle, DE-based AI-powered skincare and dermatology platform, raised $4M led by General Catalyst. <source>

RadleyCare, a Cincinnati, OH-based developer of a peer-supported behavioral healthcare services platform, raised $3M from Aurora Forge, Jackson Healthcare, Peg's Foundation, CareSource, and several family offices. <source>

Antogen, a San Francisco, CA-based life sciences tools and diagnostics company, raised an undisclosed amount led by iGrow Venture Partners. <source>

Cogensus, a Sheridan, WY-based AI health technology company focused on legacy preservation and supporting cognitive decline in older adults, received an undisclosed investment from Caduceus Capital Partners. <source>

IMU Biosciences, a London, UK-based developer of a high-resolution immune system decoding and multi-omic analysis platform, raised an undisclosed amount co-led by IQ Capital and Molten Ventures, with participation from the British Business Bank, Meltwind, and existing institutional investors. <source>

Montara Therapeutics, a San Francisco, CA-based biotech company developing brain-selective therapies for central nervous system diseases, received a research grant from the Michael J. Fox Foundation. <source>

TAPZERO, a Seoul, South Korea-based developer of a personal digital twin platform for longevity and preventive health, raised an undisclosed amount from Kakao Ventures. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.

Keep Reading